SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 29 filers reported holding SINOVAC BIOTECH LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 3.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 13,787 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q2 2021 | $55,000 | 0.0% | 13,787 | 0.0% | 0.00% | – |
| Q1 2021 | $55,000 | 0.0% | 13,787 | -38.4% | 0.00% | – |
| Q4 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q1 2020 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q4 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q3 2019 | $55,000 | 0.0% | 22,374 | 0.0% | 0.00% | – |
| Q2 2019 | $55,000 | -61.8% | 22,374 | 0.0% | 0.00% | – |
| Q1 2019 | $144,000 | -7.1% | 22,374 | 0.0% | 0.00% | – |
| Q4 2018 | $155,000 | -8.8% | 22,374 | 0.0% | 0.00% | – |
| Q3 2018 | $170,000 | – | 22,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Neumann Advisory Hong Kong Ltd | 402,844 | $3,005,000 | 1.62% |
| Sapphire Star Partners LP | 96,992 | $723,000 | 0.75% |
| Orbimed Advisors | 2,839,500 | $21,183,000 | 0.25% |
| Yorktown Management & Research Co Inc | 64,645 | $482,000 | 0.14% |
| NAVELLIER & ASSOCIATES INC | 31,865 | $238,000 | 0.03% |
| Renaissance Technologies | 5,172,930 | $41,625,000 | 0.02% |
| Freedom Investment Management, Inc. | 41,828 | $312,000 | 0.02% |
| Spark Investment Management LLC | 39,600 | $295,000 | 0.02% |
| Financial Gravity Asset Management, Inc. | 460 | $3,000 | 0.00% |
| SG Americas Securities, LLC | 24,021 | $179,000 | 0.00% |